Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M970Revenue (TTM) $M100Net Margin (%)6.9Altman Z-Score6.3
Enterprise Value $M886EPS (TTM) $0.2Operating Margin %14.4Piotroski F-Score5
P/E(ttm)151Beneish M-Score-3.0Pre-tax Margin (%)11.3Higher ROA y-yN
Price/Book5.810-y EBITDA Growth Rate %--Quick Ratio9.7Cash flow > EarningsY
Price/Sales9.75-y EBITDA Growth Rate %--Current Ratio10.9Lower Leverage y-yN
Price/Free Cash Flow200y-y EBITDA Growth Rate %7.5ROA % (ttm)3.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)4.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M33.8ROIC % (ttm)13.6Gross Margin Increase y-yN

Gurus Latest Trades with RGEN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RGENJoel Greenblatt 2016-09-30 Add0.03%$26.06 - $33.42
($30.18)
$ 28.67-5%Add 135.30%140,516
RGENJoel Greenblatt 2016-06-30 Add0.01%$21.16 - $28.84
($25.59)
$ 28.6712%Add 60.55%59,717
RGENJoel Greenblatt 2016-03-31 Add$20.93 - $28.29
($24.48)
$ 28.6717%Add 55.29%37,195
RGENJoel Greenblatt 2015-12-31 Reduce$24.52 - $34.81
($28.87)
$ 28.67-1%Reduce -5.66%23,952
RGENJoel Greenblatt 2015-09-30 Buy 0.01%$27.85 - $42.14
($36.14)
$ 28.67-21%New holding25,388
RGENJoel Greenblatt 2015-03-31 Sold Out -0.0022%$19.86 - $33.41
($25.94)
$ 28.6711%Sold Out0
RGENJoel Greenblatt 2013-12-31 Buy 0.01%$10 - $13.62
($11.92)
$ 28.67141%New holding18,532
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RGEN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


RGEN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hunt AnthonyCEO 2016-11-28Sell5,000$33.12-13.44view
RYAN THOMAS F JRDirector 2016-09-14Sell2,700$32.58-12view
RYAN THOMAS F JRDirector 2016-06-30Sell5,000$26.67.78view
RYAN THOMAS F JRDirector 2016-06-28Sell10,000$24.5916.59view
Benjamin HowardVP Business Development 2016-05-11Sell2,889$26.727.3view
Benjamin HowardVP Business Development 2015-06-09Sell35,000$38.14-24.83view
RUSCHE JAMES RSenior Vice President 2015-05-15Sell15,000$41.32-30.61view
HERLIHY WALTER CPRESIDENT, CEO 2015-05-12Sell45,431$38.97-26.43view
HERLIHY WALTER CPRESIDENT, CEO 2015-05-11Sell104,569$37.94-24.43view
RYAN THOMAS F JRDirector 2015-05-08Sell20,000$37.19-22.91view

Quarterly/Annual Reports about RGEN:

News about RGEN:

Articles On GuruFocus.com
Repligen Corp. Reports Operating Results (10-Q) Feb 09 2011 
Repligen Corp. Reports Operating Results (10-Q) Nov 02 2010 
Repligen Corp. Reports Operating Results (10-Q) Aug 05 2010 
Repligen Corp. Reports Operating Results (10-Q) Feb 04 2010 
Repligen Corp. Reports Operating Results (10-Q) Nov 05 2009 
Repligen Corp. Reports Operating Results (10-Q) Feb 06 2009 

More From Other Websites
The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin... Jan 04 2017
Repligen to Present at 35th Annual J.P. Morgan Healthcare Conference Jan 04 2017
Repligen Corp. – Value Analysis (NASDAQ:RGEN) : January 3, 2017 Jan 03 2017
3 Overlooked Drug Stocks to Watch Out for in 2017 Jan 03 2017
Repligen Corp. breached its 50 day moving average in a Bearish Manner : RGEN-US : January 2, 2017 Jan 02 2017
Blog Coverage Repligen Acquires Maker of Tangential Flow Filtration Cassettes Dec 16 2016
REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of... Dec 15 2016
Novasep Sells U.S. Subsidiary TangenX Technology Corporation, Innovator in Tangential Flow... Dec 15 2016
UPDATE -- Repligen Acquires TangenX Technology Corporation Dec 15 2016
Repligen Acquires TangenX Technology Corporation Dec 15 2016
Is Repligen Corporation (RGEN) a Good Stock to Buy? Dec 10 2016
Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : November 11, 2016 Nov 11 2016
REPLIGEN CORP Financials Nov 10 2016
Repligen to Participate in Stephens Inc. Fall Investment Conference 2016 Nov 07 2016
Edited Transcript of RGEN earnings conference call or presentation 3-Nov-16 12:30pm GMT Nov 03 2016
REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 03 2016
Repligen Reports Third Quarter 2016 Financial Results Nov 03 2016
Repligen Reports Third Quarter 2016 Financial Results Nov 03 2016
Q3 2016 Repligen Corp Earnings Release - Before Market Open Nov 03 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)